|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Pharmaceutical Price Controls in OECD Countries
The U.S. is the last member of the OECD to allow market prices to prevail for pharmaceutical products. Introducing price controls into this market would have adverse affects not only for the U.S., but possibly for global health as well.
|home spotlight commentary research events news about contact links archives|